SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,000 | +300.0% | 1,950 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -94.1% | 1,950 | 0.0% | 0.00% | – |
Q1 2022 | $17,000 | -67.3% | 1,950 | -39.6% | 0.00% | – |
Q4 2021 | $52,000 | -20.0% | 3,226 | -9.2% | 0.00% | – |
Q3 2021 | $65,000 | +35.4% | 3,553 | +2.7% | 0.00% | – |
Q2 2021 | $48,000 | -2.0% | 3,459 | +5.0% | 0.00% | – |
Q1 2021 | $49,000 | – | 3,295 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 3,932,209 | $76,246,000 | 15.85% |
Atlas Venture Associates XI, LLC | 1,376,968 | $26,700,000 | 4.23% |
Atlas Venture Associates IX, LLC | 1,376,968 | $26,700,000 | 4.23% |
BVF INC/IL | 2,243,278 | $43,497,000 | 1.71% |
AWM Investment Company, Inc. | 372,755 | $7,228,000 | 0.92% |
Alphabet Inc. | 889,979 | $17,257,000 | 0.83% |
Rock Springs Capital Management LP | 1,235,000 | $23,947,000 | 0.51% |
Novo Holdings A/S | 576,702 | $11,182,000 | 0.48% |
Artal Group S.A. | 500,000 | $9,695,000 | 0.21% |
Granahan Investment Management | 420,320 | $8,150,000 | 0.18% |